Physician profile
Benjamin Zaremski
NPI 1912080524
$3,931.08
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $900 · 2021: $1,341 · 2022: $367.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $846.42 | 2019-2022 | |
| Biotronik INC. | $557.87 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $534.60 | 2019-2022 | |
| Amgen INC. | $389.83 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $316.61 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $305.67 | 2019-2021 | |
| Amarin Pharma, INC. | $216.96 | 2019-2021 | |
| Pfizer INC. | $206.05 | 2019-2022 | |
| Novo Nordisk INC | $109.09 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.28 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.90 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $69.73 | 2019-2022 | |
| Edwards Lifesciences Corporation | $39.65 | 2019 | |
| Esperion Therapeutics, INC. | $29.91 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $27.63 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $24.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.54 | 2019 | |
| Metuchen Pharmaceuticals | $16.62 | 2020 | |
| Merck Sharp & Dohme LLC | $12.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Zaremski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.